Literature DB >> 1320356

Detection of human papillomavirus in primary hepatocellular carcinoma.

F Scinicariello1, T Sato, C S Lee, H C Hsu, T S Chan, S K Tyring.   

Abstract

Human papillomaviruses (HPV) have been linked causally to some human cancers such as cervical carcinoma. To determine whether any additional type of human malignancy contained HPV DNA, we examined 16 hepatocellular carcinoma (HCC) specimens by Southern blot technique and by polymerase chain reaction (PCR). One HCC contained HPV 16 DNA as demonstrated by both Southern blot and PCR. Two other HCC samples contained HPV 18-related nucleotide sequences by PCR but were negative by Southern blot of genomic DNA. HPV could have been carried via blood to the liver, thus indirectly supporting the presence of an HPV viremia. Our findings suggest that oncogenic HPV might constitute a cofactor acting synergistically with hepatitis B virus (HBV) in the development of the HCC in these patients. Alternatively, the presence of HPV in the tumor tissue might be the result of an opportunistic infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320356

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  The Involvement of Human Papilloma Virus in Gastrointestinal Cancers.

Authors:  Jacek Baj; Alicja Forma; Iga Dudek; Zuzanna Chilimoniuk; Maciej Dobosz; Michał Dobrzyński; Grzegorz Teresiński; Grzegorz Buszewicz; Jolanta Flieger; Piero Portincasa
Journal:  Cancers (Basel)       Date:  2022-05-25       Impact factor: 6.575

2.  Human papillomavirus type 18 E6 and E7 genes integrate into human hepatoma derived cell line Hep G2.

Authors:  Tianzhong Ma; Zhongjing Su; Ling Chen; Shuyan Liu; Ningxia Zhu; Lifeng Wen; Yan Yuan; Leili Lv; Xiancai Chen; Jianmin Huang; Haibin Chen
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

3.  Human Papillomavirus Infection Is Associated with Decreased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients: Taiwan Nationwide Matched Cohort Study.

Authors:  Sung-Shuo Kao; Chia-Jung Li; James Cheng-Chung Wei; Cheng-Li Lin; Renin Chang; Yao-Min Hung
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.